Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:05 PM
Ignite Modification Date:
2025-12-24 @ 3:05 PM
NCT ID:
NCT01270659
Eligibility Criteria:
Inclusion Criteria:
* pain sufficient to warrant medication stronger than acetaminophen (Tylenol) or aspirin
* only if Emergency Department provider approves
* a negative pregnancy test is required for participation for women of childbearing age
Exclusion Criteria:
* If treating provider determines intravenous analgesia is required
* allergy to acetaminophen or any opiate/opioid, or lansoprazole patients currently taking phenothiazines, CNS depressants (including alcohol), or if they have taken an monoamine oxidase inhibitor (MAOI) or selective serotonin reuptake inhibitor (SSRI) in the past two weeks
* if patient has already been administered an opioid analgesic for their current injury
* patients on chronic opioids therapy or a history of opioid abuse
* breastfeeding mothers
* patients who plan to drive home after their emergency department visit
* history of phenylketonuria (due to phenylalanine in the formulation of the lansoprazole solutab)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT01270659
Study Brief:
Protocol Section:
NCT01270659